Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer - Drug Trials For Money - Paid Clinical Trials

A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer

A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer
Conditions:   Breast Cancer;   Breast Cancer Stage IV;   HER2-negative Breast Cancer;   Solid Carcinoma;   MEK1 Gene Mutation;   MEK2 Gene Mutation;   Metastatic Breast Cancer
Interventions:   Drug: Mirdametinib;   Drug: Fulvestrant
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 24, 2021 / by / in
Comments